Guangzhou Packgene Biotechnology Co Ltd is a prominent Contract Manufacturing (CMO/CDMO) and Contract Research Organisation (CRO) that plays a vital role in the pharmaceutical industry, focusing on Cell and Gene Therapy. Founded in 2014, the company is renowned for its economical, reliable, and scalable production of plasmid DNA and adeno-associated virus (AAV) vectors. Their innovative p-Alpha™ 293 AAV High-yield Platform significantly enhances AAV production capabilities, enabling substantial yields that meet the requirements for early-stage drug discovery, preclinical development, and clinical trials.

Services include:
- Regulatory Services
- Cell and Gene Therapy
- Plasmid DNA Production
- AAV Vector Production
- Finished Dosage Formulation

Guangzhou Packgene Biotechnology Co Ltd is committed to advancing the field of Cell and Gene Therapy through its innovative platforms and comprehensive service offerings. For more information, please visit packgene.com.